GSK

Expansion

GSK Unveils Plan for One of Europe’s Largest Life Science Campuses in Stevenage

GSK

Collaboration

ViiV Healthcare and Halozyme Enter Global Collaboration for ENHANZE® Drug Delivery Technology to Enable Development of “Ultra Long-Acting” Medicines for HIV

GSK

Clinical Trials

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data From the Phase 2 Blaze-4 Trial Evaluating Bamlanivimab With Vir-7831 in Low-risk Adults With Covid-19

GSK

GSK to Support Manufacture of Novavax’ COVID-19 Vaccine

GSK

COVID-19 Vaccine

Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine

GSK

COVID-19 Vaccine Collaboration

GSK and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Candidate Vaccine

GSK

HIV

ViiV Healthcare’s Injectable Formulation Dosed Every Two Months Shows Higher Efficacy than Daily Oral PrEP

GSK

FDA Approves GSK's Zejula

GSK

GSK's Asthma Biologic Approved

GSK

Vaccine

CEPI and GSK Collaborate to Develop a Vaccine for Coronavirus

GSK

Vaccine

GSK Candidate Vaccine Demonstrates Sustained Level of Protection Against Active Pulmonary Tuberculosis

GSK

Divest

GSK Agrees to Divest Rabies and Tick-Borne Encephalitis Vaccines to Bavarian Nordic

GSK

FDA Approval

GSK Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer

GSK

Investment

GSK Invests $120 million in Next-generation US Biopharmaceutical Manufacturing Facility

GSK

Announcement

GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple Myeloma

GSK

HIV Treatment

ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered Every Two Months

GSK

Leadership

GSK Announces Leadership Changes in the US

GSK

Phase III

GSK Announces Positive Headline Results in Phase 3 PRIMA Study of ZEJULA (niraparib) For Patients with Ovarian Cancer

GSK

Genomic Research

GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery

GSK